Purpose To explore the impactors of pregnancy outcomes of fetal heart defects and evaluate the influence of a multidisciplinary team cooperation approach. Methods A retrospective study of fetal cardiac defects diagnosed at our institution from January 2012 to June 2021 was carried out. Clinical data, including types of cardiac malformations, accompanying defects, genetic results, and pregnancy outcomes were analyzed. Results Among 400 fetuses, 122 belonged to group A (single heart defect without extracardiac defect), 115 in group B (single heart defect with extracardiac abnormalities), 100 in group C (multiple cardiac defects without extracardiac abnormalities), and 63 belonged to group D (multiple cardiac defects with extracardiac abnormalities). The termination rate in the four groups was 44.26%, 86.09%, 70%, and 82.54%, respectively (P<0.05). Multiple logistics regression analysis revealed that co-existence of extracardiac defects (OR 7.347, CI 3.674,14.694), with pathogenic genetic anomalies (OR 7.493, CI 2.051,27.372), higher prognosis grades (OR 6.307, CI 3.943,10.088) and diagnosed in later gestational age (OR 0.819, CI 0.753, 0.890)were significantly associated with the termination of pregnancy. The MDT group had a significantly lower rate of pregnancy termination, particularly in groups C and D (p<0.001). Conclusion It is important to process comprehensive cardiac and extracardiac ultrasound assessment and further genetic testing of fetal cardiac defects. Diagnosed gestational age, the severity of heart lesions, combined with extracardiac abnormalities, and identified pathogenic genetic abnormalities influence pregnancy outcomes. Multidisciplinary team cooperation is an effective approach and should be applied in fetal cardiac defects management to reduce unnecessary termination of pregnancy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.